Noctrix Health

About

Noctrix Health is pioneering the next generation of clinically validated wearable therapeutics designed to transform the management of chronic neurological disorders. Based in Pleasanton, California, the company has developed the world's first drug-free wearable therapy specifically targeting Restless Legs Syndrome (RLS). Their flagship product, the Nidra® Tonic Motor Activation (TOMAC) System, received FDA De Novo marketing authorization in April 2023, marking a significant milestone in non-pharmaceutical treatment options for patients who have not found relief through traditional medications. The company's innovative approach combines advanced neurostimulation technology with consumer-friendly wearable design, delivering prescription-grade therapy directly to patients. Noctrix Health's team includes medical device specialists, neuroscientists, and consumer electronics engineers working collaboratively to bridge the gap between clinical efficacy and user experience. By focusing on peripheral nerve stimulation, the company offers a non-invasive alternative that can provide symptom relief in as little as 30 minutes, improving both RLS symptoms and overall sleep quality for patients struggling with this often-debilitating condition.